Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001783732-22-000001
Filing Date
2022-04-21
Accepted
2022-04-21 12:55:18
Documents
1
Effectiveness Date
2022-04-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11434
  Complete submission text file 0001783732-22-000001.txt   12490
Mailing Address 203 CRESCENT STREET, BLDG #17, STE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET, BLDG #17, STE 102B WALTHAM MA 02453 919-949-8552
Dianthus Therapeutics, Inc. (Filer) CIK: 0001783732 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-442826 | Film No.: 22840672